
With an aging population and rising healthcare needs, there is a growing demand for quality healthcare, innovative treatments, and advanced healthcare solutions. Given the industry’s rapid innovation and significant growth potential, investing in biotech stocks could be attractive.
Therefore, investors could consider buying these three fundamentally sound biotech stocks: Exelixis, Inc. (EXEL), Gilead Sciences, Inc. (GILD), and Halozyme Therapeutics, Inc. (HALO). These companies are slated to release their second-quarter earnings this week.